Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Clinical research has indicated that FOXO4-DRI has shown promise in the following areas: Targets senescent cells FOXO4-DRI is a synthetic peptide designed to target senescent cells, which are damaged cells that stop dividing but resist apoptosis (programmed cell death)
While both peptides have been studied for tissue-regenerative properties, they appear to function through different mechanisms: BPC-157 may work primarily through growth factor-mediated pathways and nitric oxide systems
Important Cautions Dogs with active cancer: Due to the potential to stimulate cell growth and the growth of blood vessels, many veterinarians do not use BPC-157 in sick pets with known cancer or risk of having a tumor
The exception is highly potent peptides (like semaglutide) where tiny doses of concentrated solution are intentional and where specialized fine-gauge syringes may be used
US$ 25.71
US$ 27.98
US$ 23.38
US$ 20.99
US$ 23.01
